Get Sample Pages - Artificial Intelligence Enabled Drug Discovery And Clinical Trials Market Analysis

Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Research Report: Forecast (2021-2026)

By Component (Software, Service), By Application (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research), By Therapeutic Applicatio......n (Oncology, Cardiovascular Disease, Nervous System Disease, Respiratory Disorder, Metabolic Disorder, Immunologic Disease, Infectious Disease), By End-User (Biopharmaceutical Industry, Contract Research Organization (CROs), Academic Institutes and Research Centers), By Geographic Region (North America, South America, Europe, Middle East & Africa, Asia Pacific), By Countries (US, Canada, Mexico, Brazil, Argentina, Germany, France, Spain, Italy, UK, UAE, Saudi Arabia, China, India, Japan, Australia, South Korea), By Competitors (Accutar Biotechnology, Ardigen, Atomwise Inc., AiCure, LLC, Berg LLc, Cloud Pharmaceuticals, Biovista, Cyclica Inc., Symphony Innovations, GNS Healthcare) Read more

Healthcare
Jul 2021
Pages 221
Report Format: PDF, Excel, PPT

Artificial Intelligence (AI) Enabled Drug Discovery & Clinical Trials involves collecting information regarding various potential drug entities, formulating their design, followed by planning and pre-clinical trials execution. It helps in saving time, cost, and human efforts in the drug developmental process.

The “Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market” is likely to grow at a CAGR of around 23.6% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth primarily attributes to the rising demand for reducing the cost of novel drug discovery and their production. Additionally, the adoption of artificial intelligence is significantly increasing, as faster, efficient, and cost-effective drug discovery is gaining momentum amongst the pharmaceutical industry stakeholders.

The research report, “Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Analysis, 2021,” states that the burgeoning volume of data generated by the molecule screening processes & preclinical studies is another crucial factor fueling the adoption of artificial intelligence, thereby propelling the market growth.

Report Coverage	Details
Study Period	Historical Data: 2016-19
	Base Year: 2020
	Forecast Period: 2021-26
CAGR	23.6%
Regions Covered	North America: USA, Canada, Mexico
	Europe: Germany, UK, France, Italy, Spain
	Asia-Pacific: China, India, Japan, South Korea, Australia and Others
	South America: Brazil, and Argentina
	Middle East & Africa: UAE, Saudi Arabia
Key Companies Profiled	Accutar Biotechnology, Ardigen, Atomwise Inc., AiCure, LLC, Berg LLc, Cloud Pharmaceuticals, Biovista, Cyclica Inc., Symphony Innovations, GNS Healthcare
Unit Denominations	USD Million/Billion

Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Have positively impacted by COVID-19 Pandemic

With the global Covid-19 pandemic outbreak in early 2020, the pharma and biotech companies have increasingly turned to artificial intelligence to enhance precision and speed in drug development. The pandemic has set the stage for massive investments toward fast development and trials of drugs.

Moreover, the adoption of artificial intelligence helps in offering a high level of precision to the complicated and time-consuming discovery phase in the drug development process, thereby leading to faster development of drugs and lower failure risk.

Introduction
1. Product Definition
2. Research Process
3. Glossary
4. Market Segmentation
Executive Summary
Start-up Ecosystem
Impact of COVID-19 on Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market
Expert Verbatim- Interview Excerpts of 10 industry experts
Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
    1. Software
    2. Service
  2. By Application
    1. Data Aggregation and Analysis
    2. Clinical Trials
    3. Drug Design
    4. Drug Characterization
    5. Biomarker Research
  3. By Therapeutic Application
    1. Oncology
    2. Cardiovascular Disease
    3. Nervous System Disease
    4. Respiratory Disorder
    5. Metabolic Disorder
    6. Immunologic Disease
    7. Infectious Disease
    8. Others
  4. By End-User
    1. Biopharmaceutical Industry
    2. Contract Research Organization (CROs)
    3. Academic Institutes and Research Centers
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. Asia-Pacific
    5. Middle East & Africa
  6. By Company
    1. Revenue Shares
    2. Strategic Factorial Indexing
    3. Competitor Placement in MarkNtel Quadrant
North America Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
  3. By Therapeutic Application
  4. By End-User
  5. By Country
    1. US
    2. Canada
    3. Mexico
3. The US Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
4. Canada Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
5. Mexico Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
South America Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
  3. By Therapeutic Application
  4. By End-User
  5. By Country
    1. Brazil
    2. Argentina
    3. Others
3. Brazil Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
4. Argentina Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
Europe Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
  3. By Therapeutic Application
  4. By End-User
  5. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Others
3. UK Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
4. Germany Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
5. France Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
6. Italy Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
7. Spain Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. By Revenues
  2. Market Share & Analysis
    1. By Component
    2. By Application
Asia-Pacific Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
  3. By Therapeutic Application
  4. By End-User
  5. By Country
    1. China
    2. India
    3. Japan
    4. Australia
    5. South Korea
    6. Others
China Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
India Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
Japan Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
Australia Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
South Korea Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
Middle East and Africa Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
  3. By Therapeutic Application
  4. By End-User
  5. By Country
    1. UAE
    2. Saudi Arabia
    3. Others
UAE Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
Saudi Arabia Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Component
  2. By Application
Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Dynamics
1. Drivers
2. Challenges
3. Impact Analysis
Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Regulations, Product Standards
Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Value Chain Analysis
Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Intellectual Property Rights Analysis
Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Hotspots & Opportunities
Competition Outlook
1. Competitor Wise Growth Strategies
  1. Product Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Research & Development
  5. Strategic Alliances & Initiatives
2. Company Profiles
  1. Accutar Biotechnology
  2. Ardigen
  3. Atomwise Inc.
  4. AiCure, LLC
  5. Berg LLc
  6. Cloud Pharmaceuticals
  7. Biovista
  8. Cyclica Inc.
  9. Symphony Innovations
  10. GNS Healthcare
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *